KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics, page-3

  1. Rich&Poor
    1,161 Posts.
    lightbulb Created with Sketch. 859
    clock Created with Sketch.
    18/07/21
    12:08
    Post #: 54581723
    Agree, Dr Priscilla Brastianos has always championed Paxalisib (GDC-0084) for her preference in the PI3K arm of the ALLIANCE trial.

    It is a closed shop as for any trial information leaking out of her Lab.

    IMO the analysts have not valued the progress of this study, Huge potential for a Kazia share re-rating on the release of positive news.

    Regards.
    KZA Price at posting: $1.31 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.